Home » EMEA, U.S. FDA Sign Transatlantic ‘Simplification’ Pact
EMEA, U.S. FDA Sign Transatlantic ‘Simplification’ Pact
July 15, 2008
The European Medicines Agency (EMEA) and the U.S. Food and Drug Administration (FDA) will collaborate on a range of projects aimed at simplifying and streamlining administrative practices and guidelines relating to drugs.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor